Clinical Trial Update: Telaprevir in Genotype 3 HCV [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for telaprevir in genotype 3 hepatitis C (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Telaprevir (telaprevir)

Snippet

Sponsor: Queen Mary University of London | Conditions: Hepatitis C | Phase 4 | Status: COMPLETED